Cite

    Moore, E. E., Khan, O. A., Liu, D., Pechman, K. R., Acosta, L. M. Y., Bell, S. P., Landman, B. A., Blennow, K., Zetterberg, H., Hohman, T. J., Gifford, K. A., & Jefferson, A. L. (n.d.). baseline cerebrospinal fluid biomarkers of amyloidosis, phosphorylated tau, and total tau relate to greater longitudinal atrophy in regions susceptible to Alzheimer's disease‐related neurodegeneration. Alzheimer's & dementia, 16, n/a. http://access.bl.uk/ark:/81055/vdc_100115132524.0x00001a